ESC Premium Access

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Presentation

About the speaker

Doctor Eduard Sidelnkov

Amgen Europe GmbH, Zug (Switzerland)
0 follower

4 more presentations in this session

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Speaker: Ms I. Thalmann (Oxford, GB)

Thumbnail

Management of conflicts of interests of ESC guideline authors

Speaker: Professor H. Seggewiss (Wurzburg, DE)

Thumbnail

Burnout in residency: are cardiology residents more affected?

Speaker: Mr A. Sigal (Buenos Aires, AR)

Thumbnail

The assessment of the accuracy and credibility of cardiovascular health information on social media platforms

Speaker: Doctor A. Ragab (Rotterdam, NL)

Thumbnail

Access the full session

Cardiovascular Disease Prevention and Treatment: What Drives Change?

Speakers: Doctor E. Sidelnkov, Ms I. Thalmann, Professor H. Seggewiss, Mr A. Sigal, Doctor A. Ragab
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

The optimal patient pathway - how it looks like in our hospital.

28 August 2021

Open Access

Introduction & relevance of INOCA.

28 August 2021

Open Access

SMART-MI- ICMs - Discussant review.

27 August 2021

This platform is supported by

logo Novo Nordisk